$Hims & Hers Health (HIMS.US)$ options volume jumped Friday, landing the company in the 10 most active stock options, as the telehealth and wellness platform saw its shares tumble more than 22% after the Food and Drug Administration declared the end of the shortage of Novo Nordisk's weight-loss and diabetes drugs.
Shares of Hims & Hers are giving back the gains fueled by optimism over increasing revenue driven by inc...

$Sigma Healthcare Ltd (SIG.AU)$ Hold it or dump it? it's been digging into the earth's core since morning...